Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Complete Genomics; MOgene, Fluidigm; Roka Bioscience; Silicon Kinetics; Precision Biosciences; IDBS

NEW YORK (GenomeWeb News) – Investment bank Jefferies this week trimmed its 2011 and 2012 revenue forecasts for Complete Genomics after the firm recently said that it shipped fewer genomes than forecast in the fourth quarter of 2011, bringing its full-year shipments to 3,000 instead of the 3,200 that the company predicted in mid-December.

Jefferies analyst Jon Wood wrote in a research note that the bank cut its 2011 revenue forecast to $20 million from $21 million and its 2012 revenue forecast to $35 million from $40 million. He also cut the price target on Complete Genomics' stock to $7 from $12 but maintained a Buy rating.


MOgene, a genomics services provider based in St. Louis, said this week that it has added Fluidigm's Access Array sample prep technology for customers receiving targeted resequencing services.


Roka Bioscience, a spinoff of Gen-Probe, has received AOAC Performance Tested Method certification for its Listeria Detection Assay. The molecular assay runs on the firm's Atlas System, which has been developed to detect food pathogens in food and environmental samples.


San Diego-based Silicon Kinetics this week said that the Mossakowski Medical Research Center in Warsaw, Poland will serve as a demonstration site for the firm's Ski Pro system for label-free interaction analysis. The system is used to detect protein-protein, protein-drug, or protein-DNA interactions in real-time.


Precision Biosciences this week announced the formation of Precision PlantSciences, a wholly owned subsidiary focused on using Precision's Directed Nuclease Editor technology for agricultural applications. The new subsidiary will take control of all of Precision's agricultural partnerships.


IDBS has opened a new Healthcare Center of Excellence in Burlington, Mass. The Guildford, UK-based informatics firm said the center is "dedicated to the advancement of personalized medicines and improved patient outcomes through the delivery of advanced translational medicine and biomarker research informatics that bridge the worlds of clinical, molecular and image data."


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.